CVM insider trading
NYSE American HealthcareCEL SCI CORP: insider trade history from SEC Form 4 filings.
About CEL SCI CORP
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
Company website: cel-sci.com
CVM insider activity at a glance
FilingIQ tracks 184 insider transactions for CVM in filings since Jul 1, 2015. The most recent transaction is dated Sep 30, 2026.
Across the full history, 35 open-market purchases
and 12 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CVM insider trades is 62.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest CVM Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading CVM
Frequently asked
- How many insider trades does FilingIQ track for CVM?
- FilingIQ tracks 184 Form 4 insider transactions for CVM (CEL SCI CORP), covering filings from Jul 1, 2015 onwards. 4 of those are dated within the last 90 days.
- Are CVM insiders net buyers or net sellers?
- Across the full Form 4 history for CVM, 35 transactions (19%) were open-market purchases and 12 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CVM insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is CVM in?
- CEL SCI CORP (CVM) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $41.20M.
Methodology & sources
Every CVM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.